Skip to content
Study details
Enrolling now

HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients

University of Texas Southwestern Medical Center
NCT IDNCT06659952ClinicalTrials.gov data as of Apr 2026
Target enrollment

50

Study length

about 10 years

Ages

18+

Locations

1 site in TX

About this study

Researchers are testing whether heart organ transplantation from HIV+ deceased donors is as safe and effective in HIV+ recipients as transplants from HIV- deceased donors. The trial is comparing the outcomes of HIV-positive heart transplant recipients by the HIV status of the donor; HIV-positive vs. HIV-negative, to learn if this type of transplant is safe and effective for HIV+ patients.

Based on ClinicalTrials.gov records.

What participants do

  • 1.HIV-positive heart transplant

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low12%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Number of Participants With One or More Serious Adverse Experience (SAE)

Body systems

Cardiology / Heart, Immune, Infectious